MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Prepaid Expense
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Prepaid Expense of $783.72 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2019-11-13
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2019-09-30 was $769.61K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2019-06-30 was $103.62K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2019-03-31 was -$89.52K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2018-12-31 was -$90.75K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2018 was -$349.67K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2017 was -$256.92K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2016 was -$189.69K, a 269.99% decline from fiscal 2015.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2015 was $111.59K, a 272.81% increase from fiscal 2014.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 32 month |
|---|---|---|---|---|---|
| 2019-09-30 | $769.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $873.23K derived: sum of 2 quarters · filed 2019-11-13 | $783.72K 10-Q · filed 2019-11-13 | $692.96K derived: sum of 4 quarters · filed 2019-11-13 | |
| 2019-06-30 | $103.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $14.10K 10-Q · filed 2019-08-13 | -$76.65K derived: sum of 3 quarters · filed 2019-08-13 | -$85.45K derived: sum of 4 quarters · filed 2019-11-13 | |
| 2019-03-31 | -$89.52K 10-Q · filed 2019-05-13 | -$180.27K derived: sum of 2 quarters · filed 2019-05-13 | -$189.07K derived: sum of 3 quarters · filed 2019-11-13 | -$310.59K derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-12-31 | -$90.75K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$99.56K derived: sum of 2 quarters · filed 2019-11-13 | -$221.07K derived: sum of 3 quarters · filed 2019-11-13 | -$349.67K 10-K · filed 2019-04-01 | |
| 2018-09-30 | -$8.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$130.32K derived: sum of 2 quarters · filed 2019-11-13 | -$258.91K 10-Q · filed 2019-11-13 | -$464.42K derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | -$121.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$250.11K 10-Q · filed 2019-08-13 | -$455.62K derived: sum of 3 quarters · filed 2019-08-13 | -$519.87K derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | -$128.60K 10-Q · filed 2019-05-13 | -$334.10K derived: sum of 2 quarters · filed 2019-05-13 | -$398.35K derived: sum of 3 quarters · filed 2019-05-13 | -$884.13K derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-12-31 | -$205.51K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$269.75K derived: sum of 2 quarters · filed 2019-04-01 | -$755.54K derived: sum of 3 quarters · filed 2019-04-01 | -$256.92K 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$64.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$550.03K derived: sum of 2 quarters · filed 2018-11-09 | -$51.42K 10-Q · filed 2018-11-09 | -$996.00 derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | -$485.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $12.83K 10-Q · filed 2018-08-09 | $63.25K derived: sum of 3 quarters · filed 2018-08-09 | -$12.90K derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | $498.61K 10-Q · filed 2018-05-09 | $549.03K derived: sum of 2 quarters · filed 2018-05-09 | $472.88K derived: sum of 3 quarters · filed 2018-05-09 | $402.70K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | $50.42K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$25.73K derived: sum of 2 quarters · filed 2018-03-16 | -$95.91K derived: sum of 3 quarters · filed 2018-03-16 | -$189.69K 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$76.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$146.34K derived: sum of 2 quarters · filed 2017-11-14 | -$240.12K 10-Q · filed 2017-11-14 | -$350.51K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | -$70.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$163.96K 10-Q · filed 2017-08-08 | -$274.36K derived: sum of 3 quarters · filed 2018-03-16 | -$47.16K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | -$93.78K 10-Q · filed 2017-05-15 | -$204.18K derived: sum of 2 quarters · filed 2018-03-16 | $23.02K derived: sum of 3 quarters · filed 2018-03-16 | $44.39K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | -$110.40K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $116.80K derived: sum of 2 quarters · filed 2018-03-16 | $138.17K derived: sum of 3 quarters · filed 2018-03-16 | $111.59K 10-K · filed 2018-03-16 | |
| 2015-09-30 | $227.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $248.57K derived: sum of 2 quarters · filed 2016-11-14 | $221.99K 10-Q · filed 2016-11-14 | $204.85K derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $21.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$5.21K 10-Q · filed 2016-08-15 | -$22.35K derived: sum of 3 quarters · filed 2016-08-15 | $44.55K derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | -$26.58K 10-Q · filed 2016-05-13 | -$43.72K derived: sum of 2 quarters · filed 2016-05-13 | $23.18K derived: sum of 3 quarters · filed 2016-05-13 | $41.33K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2014-12-31 | -$17.14K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $49.76K derived: sum of 2 quarters · filed 2016-03-30 | $67.91K derived: sum of 3 quarters · filed 2016-03-30 | $29.93K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $66.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $85.05K derived: sum of 2 quarters · filed 2015-11-10 | $47.07K 10-Q · filed 2015-11-10 | $101.17K derived: sum of 4 quarters · filed 2015-11-10 | |
| 2014-06-30 | $18.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$19.83K 10-Q · filed 2015-08-13 | $34.27K derived: sum of 3 quarters · filed 2015-08-13 | $15.64K derived: sum of 4 quarters · filed 2015-08-13 | |
| 2014-03-31 | -$37.98K 10-Q · filed 2015-05-15 | $16.12K derived: sum of 2 quarters · filed 2015-05-15 | -$2.51K derived: sum of 3 quarters · filed 2015-05-15 | $13.39K derived: sum of 4 quarters · filed 2015-05-15 | $46.51K 10-Q · filed 2014-06-06 |
| 2013-12-31 | $54.10K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $35.47K derived: sum of 2 quarters · filed 2015-03-31 | $51.37K derived: sum of 3 quarters · filed 2015-03-31 | $84.49K 10-K · filed 2015-03-31 | |
| 2013-09-30 | -$18.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$2.73K derived: sum of 2 quarters · filed 2014-11-14 | $30.39K 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $15.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $49.02K 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | $33.13K 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |